Modified vs. Conventional Laparoscopic TAPP for Inguinal Hernia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorUniversity of Health Sciences Lahore

About this trial

This study aims to compare the outcomes of two laparoscopic techniques for repairing inguinal hernias: the modified tumescent technique (MT-TAPP) and the conventional laparoscopic transabdominal preperitoneal technique (CL-TAPP). The primary goal is to determine which technique provides better outcomes in terms of operative time, ease of pre-peritoneal space dissection, postoperative pain, and the formation of seromas. The study will involve 60 patients diagnosed with unilateral inguinal hernias, randomly assigned to either group. Participants in Group A will undergo the MT-TAPP procedure, which involves pre-peritoneal infiltration of a local anesthetic solution to improve dissection and reduce pain. Group B will undergo the standard CL-TAPP procedure. Data will be collected on various outcome measures and analyzed to identify which technique leads to quicker recovery, less postoperative pain, and fewer complications. The results of this study will help guide surgical decisions and improve patient outcomes in inguinal hernia repair.

Eligibility criteria

Qualifiers

Age: 18 to 50 years.

Gender: Both male and female participants.

Condition: Diagnosed with unilateral inguinal hernia (as per operational definition).

Health Status: ASA I-III (American Society of Anesthesiologists physical status classification), indicating that the patient is fit for surgery.

Disqualifiers

Femoral Hernias.

Incarcerated or Strangulated Hernia.

Recurrent Hernias (as per medical record).

Conditions such as heart failure or coagulation problems (e.g., PT > 15 sec).

Trial design

Treatments tested in this trial

  • Modified Tumescent Laparoscopic TAPP (MT-TAPP) for the first group.
  • Conventional Laparoscopic TAPP (CL-TAPP)

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations